Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Minority Interest (2010 - 2023)

Johnson & Johnson's (JNJ) quarterly Minority Interest came in at $1.3 billion in Q3 2023, up 113.56% quarter-over-quarter from $590.0 million in Q1 2010.

Analysis

Johnson & Johnson (JNJ) Minority Interest (2010 - 2023) Analysis & Trends

Johnson & Johnson has disclosed Minority Interest across 2 years of filings, most recently posting $1.3 billion for Q3 2023.

  • In Q3 2023, Minority Interest changed N/A year-over-year to $1.3 billion; the TTM figure through Jul 2023 stood at $1.3 billion (changed N/A YoY), while the FY2010 annual figure was $590.0 million, changed N/A from the prior year.
  • Minority Interest came in at $1.3 billion for Q3 2023 at Johnson & Johnson, up from $590.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $1.3 billion in Q3 2023 to a low of $1.3 billion in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 2, 2023 1.26 Bn
Jan 3, 2010 590.00 Mn